vs

Side-by-side financial comparison of WEIS MARKETS INC (WMK) and Xylem Inc. (XYL). Click either name above to swap in a different company.

Xylem Inc. is the larger business by last-quarter revenue ($2.1B vs $1.3B, roughly 1.6× WEIS MARKETS INC). Xylem Inc. runs the higher net margin — 8.9% vs 2.5%, a 6.4% gap on every dollar of revenue. On growth, WEIS MARKETS INC posted the faster year-over-year revenue change (5.0% vs 2.7%). Over the past eight quarters, WEIS MARKETS INC's revenue compounded faster (4.7% CAGR vs -1.0%).

Weis Markets, Inc., doing business as Weis and stylized as weis, is an American food retailer headquartered in Sunbury, Pennsylvania. It currently operates 200 stores with over 23,000 employees in Pennsylvania, Maryland, New York, New Jersey, West Virginia, Virginia, and Delaware.

Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.

WMK vs XYL — Head-to-Head

Bigger by revenue
XYL
XYL
1.6× larger
XYL
$2.1B
$1.3B
WMK
Growing faster (revenue YoY)
WMK
WMK
+2.3% gap
WMK
5.0%
2.7%
XYL
Higher net margin
XYL
XYL
6.4% more per $
XYL
8.9%
2.5%
WMK
Faster 2-yr revenue CAGR
WMK
WMK
Annualised
WMK
4.7%
-1.0%
XYL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
WMK
WMK
XYL
XYL
Revenue
$1.3B
$2.1B
Net Profit
$32.0M
$189.0M
Gross Margin
25.3%
37.8%
Operating Margin
3.2%
11.5%
Net Margin
2.5%
8.9%
Revenue YoY
5.0%
2.7%
Net Profit YoY
-5.1%
100.0%
EPS (diluted)
$1.27
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
WMK
WMK
XYL
XYL
Q1 26
$2.1B
Q4 25
$1.3B
$2.4B
Q3 25
$1.2B
$2.3B
Q2 25
$1.2B
$2.3B
Q1 25
$1.2B
$2.1B
Q4 24
$1.2B
$2.3B
Q3 24
$1.2B
$2.1B
Q2 24
$1.2B
$2.2B
Net Profit
WMK
WMK
XYL
XYL
Q1 26
$189.0M
Q4 25
$32.0M
$335.0M
Q3 25
$16.9M
$227.0M
Q2 25
$25.3M
$226.0M
Q1 25
$19.5M
$169.0M
Q4 24
$33.7M
$326.0M
Q3 24
$24.5M
$217.0M
Q2 24
$25.4M
$194.0M
Gross Margin
WMK
WMK
XYL
XYL
Q1 26
37.8%
Q4 25
25.3%
38.9%
Q3 25
24.7%
38.9%
Q2 25
25.2%
38.8%
Q1 25
24.8%
37.1%
Q4 24
25.4%
38.0%
Q3 24
24.6%
37.3%
Q2 24
25.1%
37.8%
Operating Margin
WMK
WMK
XYL
XYL
Q1 26
11.5%
Q4 25
3.2%
14.7%
Q3 25
1.7%
14.7%
Q2 25
2.5%
13.3%
Q1 25
1.8%
11.2%
Q4 24
3.3%
11.8%
Q3 24
2.3%
13.3%
Q2 24
2.6%
11.7%
Net Margin
WMK
WMK
XYL
XYL
Q1 26
8.9%
Q4 25
2.5%
14.0%
Q3 25
1.4%
10.0%
Q2 25
2.1%
9.8%
Q1 25
1.6%
8.2%
Q4 24
2.7%
14.5%
Q3 24
2.1%
10.3%
Q2 24
2.1%
8.9%
EPS (diluted)
WMK
WMK
XYL
XYL
Q1 26
$0.79
Q4 25
$1.27
$1.37
Q3 25
$0.69
$0.93
Q2 25
$0.96
$0.93
Q1 25
$0.73
$0.69
Q4 24
$1.25
$1.33
Q3 24
$0.91
$0.89
Q2 24
$0.95
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
WMK
WMK
XYL
XYL
Cash + ST InvestmentsLiquidity on hand
$214.2M
$808.0M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$1.4B
$11.0B
Total Assets
$2.0B
$17.0B
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
WMK
WMK
XYL
XYL
Q1 26
$808.0M
Q4 25
$214.2M
$1.5B
Q3 25
$177.6M
$1.2B
Q2 25
$188.8M
$1.2B
Q1 25
$337.9M
$1.1B
Q4 24
$382.3M
$1.1B
Q3 24
$381.2M
$989.0M
Q2 24
$398.7M
$815.0M
Total Debt
WMK
WMK
XYL
XYL
Q1 26
$1.9B
Q4 25
$2.0B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
Q2 24
Stockholders' Equity
WMK
WMK
XYL
XYL
Q1 26
$11.0B
Q4 25
$1.4B
$11.5B
Q3 25
$1.3B
$11.2B
Q2 25
$1.3B
$11.1B
Q1 25
$1.4B
$10.8B
Q4 24
$1.4B
$10.6B
Q3 24
$1.4B
$10.6B
Q2 24
$1.4B
$10.3B
Total Assets
WMK
WMK
XYL
XYL
Q1 26
$17.0B
Q4 25
$2.0B
$17.6B
Q3 25
$2.0B
$17.3B
Q2 25
$1.9B
$17.2B
Q1 25
$2.1B
$16.6B
Q4 24
$2.1B
$16.5B
Q3 24
$2.1B
$16.0B
Q2 24
$2.1B
$15.8B
Debt / Equity
WMK
WMK
XYL
XYL
Q1 26
0.18×
Q4 25
0.17×
Q3 25
0.18×
Q2 25
0.18×
Q1 25
0.19×
Q4 24
0.19×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
WMK
WMK
XYL
XYL
Operating Cash FlowLast quarter
$86.6M
Free Cash FlowOCF − Capex
$36.4M
FCF MarginFCF / Revenue
2.8%
Capex IntensityCapex / Revenue
3.9%
4.2%
Cash ConversionOCF / Net Profit
2.71×
TTM Free Cash FlowTrailing 4 quarters
$4.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
WMK
WMK
XYL
XYL
Q1 26
Q4 25
$86.6M
$543.0M
Q3 25
$59.2M
$360.0M
Q2 25
$56.6M
$305.0M
Q1 25
$4.9M
$33.0M
Q4 24
$87.1M
$575.0M
Q3 24
$25.8M
$311.0M
Q2 24
$40.3M
$288.0M
Free Cash Flow
WMK
WMK
XYL
XYL
Q1 26
Q4 25
$36.4M
$460.0M
Q3 25
$-4.7M
$281.0M
Q2 25
$1.4M
$207.0M
Q1 25
$-28.3M
$-38.0M
Q4 24
$33.7M
$475.0M
Q3 24
$-16.5M
$237.0M
Q2 24
$10.2M
$215.0M
FCF Margin
WMK
WMK
XYL
XYL
Q1 26
Q4 25
2.8%
19.2%
Q3 25
-0.4%
12.4%
Q2 25
0.1%
9.0%
Q1 25
-2.4%
-1.8%
Q4 24
2.7%
21.1%
Q3 24
-1.4%
11.3%
Q2 24
0.9%
9.9%
Capex Intensity
WMK
WMK
XYL
XYL
Q1 26
4.2%
Q4 25
3.9%
3.5%
Q3 25
5.1%
3.5%
Q2 25
4.5%
4.3%
Q1 25
2.8%
3.4%
Q4 24
4.3%
4.4%
Q3 24
3.6%
3.5%
Q2 24
2.5%
3.4%
Cash Conversion
WMK
WMK
XYL
XYL
Q1 26
Q4 25
2.71×
1.62×
Q3 25
3.50×
1.59×
Q2 25
2.24×
1.35×
Q1 25
0.25×
0.20×
Q4 24
2.59×
1.76×
Q3 24
1.05×
1.43×
Q2 24
1.58×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

WMK
WMK

Grocery$1.0B80%
Pharmacy$186.7M14%
Fuel Product$66.5M5%
Services$5.9M0%
Manufacturing$2.2M0%

XYL
XYL

Revenue from products$1.8B83%
Revenue from services$368.0M17%

Related Comparisons